71 research outputs found
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data
BackgroundThe plasma-derived, highly purified, nanofiltered C1-inhibitor concentrate (Berinert; âpnfC1-INHâ) is approved in the United States for treating hereditary angioedema (HAE) attacks and in many European countries for attack treatment and short-term prophylaxis.ObjectiveThe objective of this study was to describe safety and usage patterns of pnfC1-INH.MethodsA multicenter, observational, registry was conducted between 2010 and 2014 at 30 United States and 7 European sites to obtain both prospective (occurring after enrollment) and retrospective (occurring before enrollment) safety and usage data on subjects receiving pnfC1-INH for any reason.ResultsOf 343 enrolled patients, 318 received 1 or more doses of pnfC1-INH for HAE attacks (11,848 infusions) or for prophylaxis (3142 infusions), comprising the safety population. Median dosages per infusion were 10.8 IU/kg (attack treatment) and 16.6 IU/kg (prophylaxis). Approximately 95% of infusions were administered outside of a health care setting. No adverse events (AEs) were reported in retrospective data. Among prospective data (n = 296 subjects; 9148 infusions), 252 AEs were reported in 85 (28.7%) subjects (rate of 0.03 events/infusion); 9 events were considered related to pnfC1-INH. Two thromboembolic events were reported in subjects with thrombotic risk factors. No patient was noted to have undergone viral testing for suspected blood-borne infection during registry participation.ConclusionsThe findings from this large, international patient registry documented widespread implementation of pnfC1-INH self-administration outside of a health care setting consistent with current HAE guidelines. These real-world data revealed pnfC1-INH usage for a variety of reasons in patients with HAE and showed a high level of safety regardless of administration setting or reason for use
MicroRNA reexpression as differentiation therapy in cancer
Since their discovery in the early 2000s, microRNAs (miRNAs) and their penchant for RNA interference have taken the scientific community by storm, working their way into virtually every corner of biological inquiry. The very nature of their action, the ability to simultaneously extinguish the expression of a multitude of genes and negate their functions, immediately suggested therapeutic promise. In this issue of the JCI, a step toward the realization of this promise is described. Taulli et al. demonstrate that the miRNAs miR-1/miR-206, which are routinely lost in advanced, poorly differentiated rhabdomyosarcoma (RMS) but characteristically expressed in the mature skeletal muscle from which these tumors arise, restore the myogenic differentiation program and block the tumorigenic phenotype (see the related article beginning on page 2366). Their data support the notion that these small RNAs, effectively functioning as âmicro-sheriffsâ by restoring myogenic law and order, hold substantial clinical potential as differentiation therapy for RMS and perhaps other solid tumors. miRNA reexpression therapy constitutes a novel approach to handcuff oncogenes and arrest tumor development
The quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod
Violence Before Identity: An Analysis of Identity Politics
Violence is a force for creating integrities as well as one that violates, pollutes and destroys already existing entities. In this paper I address the role of what Ariella Azoulay terms the âpolitical imaginationâ in constituting social aggregates committed to the defence of a community itself brought into being by the imagining of a force dedicated to its destruction. Such a groupâs perception of what Laclau and Mouffe call an âantagonismâ spurs it to mark out and defend its boundaries with violence - a violence often manifested aggressively (pre-emptively). Collective perceptions of an otherâs antagonism are often overdetermined, either by historical memory or political manipulation, and it is often the case that an enemy is sited and a programme of âdefensiveâ violence inaugurated without any ârealâ justification. Here I demonstrate, using events drawn from the formation of the State of Israel and the collapse of what is now âFormer Yugoslaviaâ, that it is in designating an other against which destructive violence must be mobilized that an entity realizes - through the negation of that it would negate - what it is it fights to defend
Estimating Implied Valuation Parameters: Extension and Application to Ground Lease Rentals
Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations
- âŠ